This document is an excerpt from the EUR-Lex website
Document 62020TN0679
Case T-679/20: Action brought on 13 November 2020 — Dr. August Wolff v EUIPO — Combe International (Vagisan)
Case T-679/20: Action brought on 13 November 2020 — Dr. August Wolff v EUIPO — Combe International (Vagisan)
Case T-679/20: Action brought on 13 November 2020 — Dr. August Wolff v EUIPO — Combe International (Vagisan)
IO C 19, 18.1.2021, p. 63–64
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
18.1.2021 |
EN |
Official Journal of the European Union |
C 19/63 |
Action brought on 13 November 2020 — Dr. August Wolff v EUIPO — Combe International (Vagisan)
(Case T-679/20)
(2021/C 19/68)
Language of the case: English
Parties
Applicant: Dr. August Wolff GmbH & Co. KG Arzneimittel (Bielefeld, Germany) (represented by: A. Thünken, lawyer)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Combe International Ltd (New York, New York, United States)
Details of the proceedings before EUIPO
Proprietor of the trade mark at issue: Applicant before the General Court
Trade mark at issue: International registration designating the European Union in respect of the word mark Vagisan — International registration designating the European Union No 10 985 168
Procedure before EUIPO: Cancellation proceedings
Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 3 September 2020 in Case R 2459/2019-4
Form of order sought
The applicant claims that the Court should:
|
— |
annul the contested decision; |
|
— |
annul the decision of the Cancellation Division of the EUIPO No 000018101 C of 11 September 2019, |
|
— |
order the EUIPO and, as the case may be, the intervener to bear the costs of the proceedings and the costs incurred by proceedings before the EUIPO. |
Plea in law
|
— |
Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |